Cart
sales@molnova.com
STYLOPINE
CAS No. 4312-32-7
STYLOPINE( —— )
Catalog No. M24394 CAS No. 4312-32-7
(-)-STYLOPINE is a natural product from Chelidonium majus L.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 87 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 236 | In Stock |
|
| 50MG | 350 | In Stock |
|
| 100MG | 516 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTYLOPINE
-
NoteResearch use only, not for human use.
-
Brief Description(-)-STYLOPINE is a natural product from Chelidonium majus L.
-
Description(-)-STYLOPINE is a natural product from Chelidonium majus L.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2|iNOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4312-32-7
-
Formula Weight323.35
-
Molecular FormulaC19H17NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CN2CC3=C(CC2C4=CC5=C(C=C41)OCO5)C=CC6=C3OCO6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jang S , Kim B H , Lee W Y , et al. Stylopine fromChelidonium majus inhibits LPS-Induced inflammatory mediators in RAW 264.7 cells[J]. Archives of Pharmacal Research, 2004, 27(9):923-929.
molnova catalog
related products
-
Meclofenoxate hydroc...
Meclofenoxate hydrochloride, an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA), has been shown to improve memory, have a mentally stimulating effect, and improve general cognition.
-
Diciofenac
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) taken or applied to reduce inflammation and as an analgesic reducing pain in certain conditions. It is supplied as or contained in medications under a variety of trade names.
-
Gomisin A
Gomisin A may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways.
